<DOC>
	<DOC>NCT01129271</DOC>
	<brief_summary>Primary objective: - Investigate the potential food effect on Adenosine diphosphate(ADP)-induced platelet aggregation after 5-day repeated doses of clopidogrel (300 mg loading dose followed by 4 days 75 mg/day) in healthy subjects Secondary objectives are to investigate the potential food effect on: - ADP-induced platelet aggregation after 300 mg loading dose of clopidogrel - Pharmacokinetic profiles of clopidogrel and its active metabolite after 5-day repeated doses of clopidogrel</brief_summary>
	<brief_title>Food Effect Study on Pharmacodynamic and Bioavailability of Clopidogrel 300/75 mg in Healthy Subjects</brief_title>
	<detailed_description>The total duration per subject is 8-9 weeks broken down as follows: - Screening: 2 to 21 days before the first dosing - Fed period: 7 days including 5 treatment days - Washout: at least 14 days after last dosing - Fasted period: 7 days including 5 treatment days - End of study: 7 to 10 days after the last dosing</detailed_description>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>Healthy male subjects: as determined by medical history, physical examination including vital signs and clinical laboratory tests with a body weight between 50kg and 95 kg and a Body Mass Index (BMI) between 18 and 30 kg/m2 Evidence of inherited disorder of coagulation/hemostasis functions Smoking more than 5 cigarettes or equivalent per day Abnormal hemostasis screen Any contraindication to clopidogrel Unability to abstain from intake of any drug affecting haemostasis throughout the whole study duration The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>